Qunying Wu

453 total citations
15 papers, 351 citations indexed

About

Qunying Wu is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Qunying Wu has authored 15 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Qunying Wu's work include MicroRNA in disease regulation (4 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (3 papers). Qunying Wu is often cited by papers focused on MicroRNA in disease regulation (4 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (3 papers). Qunying Wu collaborates with scholars based in China and United States. Qunying Wu's co-authors include Zhenhua Lin, Shuangping Liu, Liyan Chen, Yan Zhang, Yang� Yang, Xuelian Cui, Hai Lin, Xing Xie, Hui-Feng Wang and Chenxia Zhang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Human Pathology and Journal of Experimental & Clinical Cancer Research.

In The Last Decade

Qunying Wu

14 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qunying Wu China	10	243	100	62	58	45	15	351
Ludmila de Faro Valverde Brazil	14	229 0.9×	48 0.5×	32 0.5×	115 2.0×	75 1.7×	31	451
Brandon Carter‐Cooper United States	13	222 0.9×	65 0.7×	15 0.2×	70 1.2×	36 0.8×	25	350
Sylaja Murikipudi United States	6	225 0.9×	95 0.9×	46 0.7×	238 4.1×	21 0.5×	8	470
Matthew Sobo United States	7	274 1.1×	58 0.6×	34 0.5×	253 4.4×	55 1.2×	8	494
Florence Giffard France	13	320 1.3×	173 1.7×	12 0.2×	90 1.6×	15 0.3×	23	454
Jade Mims United States	7	176 0.7×	133 1.3×	15 0.2×	50 0.9×	15 0.3×	7	356
Lisa Polin United States	12	234 1.0×	22 0.2×	32 0.5×	111 1.9×	100 2.2×	19	392
Junheng Zheng China	5	235 1.0×	128 1.3×	11 0.2×	180 3.1×	18 0.4×	7	404
H-S Hsu Taiwan	6	228 0.9×	120 1.2×	13 0.2×	125 2.2×	12 0.3×	6	441
Nadia Vezzio-Vié France	7	248 1.0×	51 0.5×	12 0.2×	180 3.1×	19 0.4×	10	363

Countries citing papers authored by Qunying Wu

Since Specialization

Citations

This map shows the geographic impact of Qunying Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qunying Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qunying Wu more than expected).

Fields of papers citing papers by Qunying Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qunying Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qunying Wu. The network helps show where Qunying Wu may publish in the future.

Co-authorship network of co-authors of Qunying Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Qunying Wu. A scholar is included among the top collaborators of Qunying Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qunying Wu. Qunying Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Jing, Ling, et al.. (2024). Curzerenone inactivates the nuclear factor-kappa B signaling to suppress malignancy and immune evasion in cervical cancer by targeting CSNK2B. Human Cell. 38(1). 35–35. 2 indexed citations

Hou, Qingzhi, et al.. (2021). Serum iron status and the risk of breast cancer in the European population: a two-sample Mendelian randomisation study. Genes & Nutrition. 16(1). 9–9. 11 indexed citations

Zhu, Jiamin, et al.. (2021). Knockdown of DIAPH3 Inhibits the Proliferation of Cervical Cancer Cells through Inactivating mTOR Signaling Pathway. Journal of Oncology. 2021. 1–16. 7 indexed citations

Wu, Qunying, Xing Xie, Yiming Huang, et al.. (2020). N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer. Journal of Cancer. 12(3). 682–692. 40 indexed citations

Zhu, Lin, et al.. (2020). CAPN6 Regulates Uterine Leiomyoma Cell Proliferation and Apoptosis through the Rac1-Dependent Signaling Pathway.. PubMed. 50(1). 24–30. 7 indexed citations

Wu, Qunying, Chenxia Zhang, Qiong Wang, et al.. (2018). miR-20a inhibits the killing effect of natural killer cells to cervical cancer cells by downregulating RUNX1. Biochemical and Biophysical Research Communications. 505(1). 309–316. 24 indexed citations

Yang, Yang, Qunying Wu, Nan Li, et al.. (2018). Upregulation of Tiam1 contributes to cervical cancer disease progression and indicates poor survival outcome. Human Pathology. 75. 179–188. 10 indexed citations

Ling, Jing, et al.. (2018). The epidemiological characteristics of maternal syphilis and neonatal outcomes with intervention in Jiangyin from 2014 to 2015. Clinical and Experimental Obstetrics & Gynecology. 45(3). 441–445.

Jing, Ling, Jiang Li, Chenxia Zhang, et al.. (2015). Upregulation of miR-197 inhibits cell proliferation by directly targeting IGFBP5 in human uterine leiomyoma cells. In Vitro Cellular & Developmental Biology - Animal. 51(8). 835–842. 17 indexed citations

10.

Yang, Yang�, Yan Zhang, Qunying Wu, et al.. (2014). Clinical implications of high NQO1 expression in breast cancers. Journal of Experimental & Clinical Cancer Research. 33(1). 14–14. 147 indexed citations

11.

Wu, Huazhang, et al.. (2013). Promoter polymorphisms of DNA methyltransferase 3B and risk of hepatocellular carcinoma. Biomedical Reports. 1(5). 771–775. 11 indexed citations

12.

Wu, Qunying, Sen Lu, Ling Wang, et al.. (2012). DNMT3A rs36012910 A>G polymorphism and gastric cancer susceptibility in a Chinese population. Molecular Biology Reports. 39(12). 10949–10955. 13 indexed citations

13.

Zhao, Zhujiang, Can Li, Yunwei Song, et al.. (2011). Association of the DNMT3A −448A>G polymorphism with genetic susceptibility to colorectal cancer. Oncology Letters. 3(2). 450–454. 18 indexed citations

14.

Wu, Qunying, et al.. (2008). DEK overexpression in uterine cervical cancers. Pathology International. 58(6). 378–382. 42 indexed citations

15.

Lin, Zhenhua, Mingzhu Liu, Yiwei Zhao, et al.. (2006). [Study of p16(INK4A) expression and DNA ploidy in HPV-negative cervical cancers and precursors].. PubMed. 35(7). 412–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact